BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38615005)

  • 1. The feasibility of half-dose contrast-enhanced scanning of brain tumours at 5.0 T: a preliminary study.
    Jiang Z; Sun W; Xu D; Mei H; Yuan J; Song X; Ma C; Xu H
    BMC Med Imaging; 2024 Apr; 24(1):88. PubMed ID: 38615005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
    Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
    J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
    Krautmacher C; Willinek WA; Tschampa HJ; Born M; Träber F; Gieseke J; Textor HJ; Schild HH; Kuhl CK
    Radiology; 2005 Dec; 237(3):1014-9. PubMed ID: 16237142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
    Zhou ZR; Shen TZ; Chen XR; Peng WJ
    Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning enables reduced gadolinium dose for contrast-enhanced brain MRI.
    Gong E; Pauly JM; Wintermark M; Zaharchuk G
    J Magn Reson Imaging; 2018 Aug; 48(2):330-340. PubMed ID: 29437269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
    Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
    Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumours at 7T MRI compared to 3T--contrast effect after half and full standard contrast agent dose: initial results.
    Noebauer-Huhmann IM; Szomolanyi P; Kronnerwetter C; Widhalm G; Weber M; Nemec S; Juras V; Ladd ME; Prayer D; Trattnig S
    Eur Radiol; 2015 Jan; 25(1):106-12. PubMed ID: 25194707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine.
    DeLano MC; Spampinato MV; Chang EY; Barr RG; Lichtenstein RJ; Colosimo C; Vymazal J; Wen Z; Lin DDM; Kirchin MA; Pirovano G
    J Magn Reson Imaging; 2021 Nov; 54(5):1660-1675. PubMed ID: 34018290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
    Wintersperger BJ; Runge VM; Biswas J; Reiser MF; Schoenberg SO
    Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Dose Reduction to Contrast Maximization: Can Deep Learning Amplify the Impact of Contrast Media on Brain Magnetic Resonance Image Quality? A Reader Study.
    Bône A; Ammari S; Menu Y; Balleyguier C; Moulton E; Chouzenoux É; Volk A; Garcia GCTE; Nicolas F; Robert P; Rohé MM; Lassau N
    Invest Radiol; 2022 Aug; 57(8):527-535. PubMed ID: 35446300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1-weighted fluid-attenuated inversion recovery and T1-weighted fast spin-echo contrast-enhanced imaging: a comparison in 20 patients with brain lesions.
    Al-Saeed O; Ismail M; Athyal RP; Rudwan M; Khafajee S
    J Med Imaging Radiat Oncol; 2009 Aug; 53(4):366-72. PubMed ID: 19695043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of contrast medium use for neuroimaging at 3.0 T: utility of IR-FSE compared to other T1-weighted pulse sequences.
    Fischbach F; Bruhn H; Pech M; Neumann F; Ricke J; Felix R; Hoffmann KT
    J Comput Assist Tomogr; 2005; 29(4):499-505. PubMed ID: 16012308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D T1-weighted turbo spin echo contrast-enhanced MRI at 1.5 T for frameless brain metastases radiotherapy.
    Yuan J; Law SCK; Wong KK; Lo GG; Kam MKM; Kwan WH; Xue C; Wong OL; Yu SK; Cheung KY
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1749-1759. PubMed ID: 34363123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR susceptibility contrast imaging using a 2D simultaneous multi-slice gradient-echo sequence at 7T.
    Bian W; Kerr AB; Tranvinh E; Parivash S; Zahneisen B; Han MH; Lock CB; Goubran M; Zhu K; Rutt BK; Zeineh MM
    PLoS One; 2019; 14(7):e0219705. PubMed ID: 31314813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of half-dose gadolinium-enhanced MRI and magnetization transfer saturation in brain tumors.
    Haba D; Pasco Papon A; Tanguy JY; Burtin P; Aube C; Caron-Poitreau C
    Eur Radiol; 2001; 11(1):117-22. PubMed ID: 11194902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wave-controlled aliasing in parallel imaging (Wave-CAIPI): Accelerating speed for the MRI-based diagnosis of enhancing intracranial lesions compared to magnetization-prepared gradient echo.
    Oh H; Yim Y; Chung MS; Byun JS
    PLoS One; 2023; 18(5):e0285089. PubMed ID: 37146026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of using half-dose Gd-BOPTA for delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at the knee, compared with standard-dose Gd-DTPA.
    Rehnitz C; Do T; Klaan B; Burkholder I; Barié A; Wuennemann F; Kauczor HU; Weber MA
    J Magn Reson Imaging; 2020 Jan; 51(1):144-154. PubMed ID: 31141254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced radial 3D fat-suppressed T1-weighted gradient-recalled echo sequence versus conventional fat-suppressed contrast-enhanced T1-weighted studies of the head and neck.
    Wu X; Raz E; Block TK; Geppert C; Hagiwara M; Bruno MT; Fatterpekar GM
    AJR Am J Roentgenol; 2014 Oct; 203(4):883-9. PubMed ID: 25247956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.